HCA Healthcare price target raised to $350 from $325 at Jefferies

Jefferies raised the firm’s price target on HCA Healthcare to $350 from $325 and keeps a Buy rating on the shares. HCA’s "solid Q1" and corresponding guidance raise "underscore the strength of its fundamentals," the analyst tells investors. Even after management raised FY23 guidance, the firm sees room for further EBITDA upside, particularly as markets normalize out of COVID and the company sees improving labor trends, the analyst added.